广西中医药
廣西中醫藥
엄서중의약
GUANGXI JOURNAL OF TRADITIONAL
2001年
1期
5-6
,共2页
韦湘林%方显明%钱海凌%黄敏%杨才坤%黄彬%庞宇舟%Pang Yuzhou
韋湘林%方顯明%錢海凌%黃敏%楊纔坤%黃彬%龐宇舟%Pang Yuzhou
위상림%방현명%전해릉%황민%양재곤%황빈%방우주%Pang Yuzhou
高脂血症%调脂胶囊%多稀康%非诺贝特
高脂血癥%調脂膠囊%多稀康%非諾貝特
고지혈증%조지효낭%다희강%비낙패특
目的：观察调脂胶囊对高脂血症的疗效。方法：将159例高脂血症患者随机分为3组，观察组75例服调脂胶囊，对照1组52例服多稀康，对照2组32例服非诺贝特。结果：3组对血脂的总有效率分别为：92.0％、827％和906％。观察组与对照1组总胆固醇(TC)、甘油三脂(TG)、低密度脂蛋白(LDL)、高密度脂蛋白(HDL)治疗均值比较均P<0.05；与对照2组比较TGP<0.05，其余各项血脂均P>0.05。结论：各组均有良好的降脂、调脂作用，但观察组优于多稀康，对TG作用优于非诺贝特。
目的：觀察調脂膠囊對高脂血癥的療效。方法：將159例高脂血癥患者隨機分為3組，觀察組75例服調脂膠囊，對照1組52例服多稀康，對照2組32例服非諾貝特。結果：3組對血脂的總有效率分彆為：92.0％、827％和906％。觀察組與對照1組總膽固醇(TC)、甘油三脂(TG)、低密度脂蛋白(LDL)、高密度脂蛋白(HDL)治療均值比較均P<0.05；與對照2組比較TGP<0.05，其餘各項血脂均P>0.05。結論：各組均有良好的降脂、調脂作用，但觀察組優于多稀康，對TG作用優于非諾貝特。
목적：관찰조지효낭대고지혈증적료효。방법：장159례고지혈증환자수궤분위3조，관찰조75례복조지효낭，대조1조52례복다희강，대조2조32례복비낙패특。결과：3조대혈지적총유효솔분별위：92.0％、827％화906％。관찰조여대조1조총담고순(TC)、감유삼지(TG)、저밀도지단백(LDL)、고밀도지단백(HDL)치료균치비교균P<0.05；여대조2조비교TGP<0.05，기여각항혈지균P>0.05。결론：각조균유량호적강지、조지작용，단관찰조우우다희강，대TG작용우우비낙패특。
Purpose: To observe the clinical effects of Tiaozhi Capsule on hyperlipemia. Methods: 159 cases with the disease were randomly divided into 3 groups. 75 cases in the observation group were given Tiaozhi Capsule, 52 cases in the control group I Duo Xikang and 32 cases in the control group II Fenofibraturn. Results: The total effective rates of the three groups in blood－ lipid were 92％ , 82.7％ and 90.6％ respectively. Through the comparison between the observation group and the control group I, the total therapertic mean in TC, TG, LDL and HDL in both groups were P<0.05. But compared with the control group II, TG in the observation group was P< 0.05, while the blood － lipid in all the other items was P>0.05. Conclusions: The medicines used in each group can lower or regulate the blood－ lipid. However, Tiaozhi Capsule used in the observation group has better effects than Duo Xikang and also has better effects on TG than Fenofibraturn used in the control group II.
